This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Aragon Pharmaceuticals, Inc.. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: Nhin Lu: Innovator in Androgen Receptor Therapy
Introduction
Nhin Lu is a prominent inventor based in San Diego, CA (US). He has made significant contributions to the field of androgen receptor therapy, particularly in developing methods and compositions that enhance treatment options for patients.
Latest Patents
Nhin Lu holds a patent for "Methods and compositions for determining resistance to androgen receptor therapy." This patent describes modified androgen receptor polypeptides that are resistant to inhibition by androgen receptor inhibitors. The patent also details compositions, combinations, and kits containing these modified polypeptides, as well as methods for using them as screening agents. Furthermore, it discusses third-generation androgen receptor modulators that inhibit the activity of these modified polypeptides. The patent outlines pharmaceutical compositions and medicaments that include these compounds, which can be used for treating diseases, including castration-resistant prostate cancers.
Career Highlights
Nhin Lu is associated with Aragon Pharmaceuticals, Inc., where he continues to work on innovative solutions in the field of cancer treatment. His research focuses on enhancing the efficacy of androgen receptor modulators, which are crucial for patients with specific types of cancers.
Collaborations
Nhin Lu collaborates with notable colleagues, including James David Joseph and Jeffrey H. Hager. Their combined expertise contributes to advancing research and development in androgen receptor therapies.
Conclusion
Nhin Lu's work in developing methods and compositions for androgen receptor therapy represents a significant advancement in cancer treatment. His innovative approach and collaboration with other experts in the field continue to pave the way for new therapeutic options.